These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8391040)

  • 1. Gene expression regulation for interferon-alpha in hepatocellular carcinoma.
    d'Arville CN; Nouri-Aria KT; Johnson P; Williams R
    J Hepatol; 1993 Mar; 17(3):339-46. PubMed ID: 8391040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.
    d'Arville CN; Nouri-Aria KT; Johnson P; Williams R
    Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection.
    Nouri-Aria KT; Arnold J; Davison F; Portmann BC; Meager A; Morris AG; Alexander GJ; Eddleston AL; Williams R
    Hepatology; 1991 Jun; 13(6):1029-34. PubMed ID: 2050318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus related hepatocellular carcinoma: chronicity of infection--the opening to different pathways of malignant transformation?
    Schröder CH; Zentgraf H
    Biochim Biophys Acta; 1990 Dec; 1032(2-3):137-56. PubMed ID: 2175655
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
    Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.
    Wong JB; Koff RS; Tinè F; Pauker SG
    Ann Intern Med; 1995 May; 122(9):664-75. PubMed ID: 7702228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization.
    Otsuru A; Nagataki S; Koji T; Tamaoki T
    Cancer; 1988 Sep; 62(6):1105-12. PubMed ID: 2457423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.
    Lin KJ; Lin TM; Wang CH; Liu HC; Lin YL; Eng HL
    Hum Pathol; 2013 Apr; 44(4):534-41. PubMed ID: 23069256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.
    Mazzella G; Accogli E; Sottili S; Festi D; Orsini M; Salzetta A; Novelli V; Cipolla A; Fabbri C; Pezzoli A; Roda E
    J Hepatol; 1996 Feb; 24(2):141-7. PubMed ID: 8907566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.
    Livni N; Eid A; Ilan Y; Rivkind A; Rosenmann E; Blendis LM; Shouval D; Galun E
    Cancer; 1995 May; 75(10):2420-6. PubMed ID: 7736384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma.
    Dejean A; de Thé H
    Mol Biol Med; 1990 Jun; 7(3):213-22. PubMed ID: 2170809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma.
    Roy G; Roy P; Bhattacharjee A; Shahid M; Misbah M; Gupta S; Husain M
    Int J Biol Markers; 2018 Aug; 33(3):283-292. PubMed ID: 29882487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma.
    Diamantis ID; McGandy CE; Chen TJ; Liaw YF; Gudat F; Bianchi L
    J Hepatol; 1994 Mar; 20(3):405-9. PubMed ID: 8014454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases.
    Leung NW; Tam JS; Lau GT; Leung TW; Lau WY; Li AK
    Cancer; 1994 Feb; 73(4):1143-8. PubMed ID: 8313316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
    Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
    Xiang LY; Ou HH; Liu XC; Chen ZJ; Li XH; Huang Y; Yang DH
    Tumour Biol; 2017 Jun; 39(6):1010428317709128. PubMed ID: 28639884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
    Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
    Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.